This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Institut Pasteur, Centre National De La Recherche Scientifique. Active years: 2011-2013.
Company Filing History:
4 out of 897 
2 out of 5,383 
Years Active: 2011-2013
Title: The Innovative Contributions of Shirley Longacre
Introduction
Shirley Longacre is a notable inventor based in Paris, France. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant polypeptides. With a total of 4 patents to her name, her work has had a considerable impact on scientific research and applications.
Latest Patents
Among her latest patents, Shirley Longacre has developed constructs that involve nucleic acids encoding MSP4 and MSP5. These constructs lead to the production of recombinant MSP4 and MSP5 polypeptides, which are expressed as soluble, secreted polypeptides in a baculovirus-insect cell expression system. Notably, it was discovered that these recombinant polypeptides contain an EGF-like domain at the C-terminus, which is properly folded in the polypeptide.
Career Highlights
Shirley Longacre has had a distinguished career, working with prestigious organizations such as Institut Pasteur and the Centre Nationale De La Recherche Scientifique. Her research has contributed to advancements in biotechnology and has been recognized within the scientific community.
Collaborations
Throughout her career, Shirley has collaborated with talented individuals, including Hannah Polson and Ronald Perraut. These collaborations have further enriched her research and innovation efforts.
Conclusion
Shirley Longacre's contributions to biotechnology through her patents and collaborations highlight her role as a significant inventor in her field. Her work continues to influence scientific advancements and applications.